Tissue-engineered autologous bladders for patients needing cystoplasty

  title={Tissue-engineered autologous bladders for patients needing cystoplasty},
  author={Anthony Atala and Stuart B. Bauer and Shay Soker and James J. Yoo and Alan B. Retik},
  journal={The Lancet},

Figures from this paper

Augmentation cystoplasty in the patient with neurogenic bladder

Enterocystoplasty remains the gold standard for AC, though more research is needed to better evaluate the morbidity of different surgical techniques and the indications for concomitant surgeries.

Urinary bladder augmentation with acellular biologic scaffold-A preclinical study in a large animal model.

BAM seems to be a promising biomaterial for reconstruction of large urinary bladder wall defects in a long-term porcine model and further research on cell-seeded BAM to enhance urinary bladder regeneration is required.

Bladder tissue engineering: a literature review.

Bladder Bioengineering: Our Experience

Bladder regeneration is feasible by tissue engineering techniques in animal models and in humans, but functional and histological results are not as with normal bladder wall.

Alloplastic bladder substitution: are we making progress?

A comprehensive review of the literature was performed using the Medline National Library of Medicine database and Google Scholar to provide a summary of the evolution of alloplastic bladder substitution.



Bladder reconstruction—from cells to materials

If tissue-engineered products are to have therapeutic application in bladder reconstruction, a number of issues remain to be addressed; these issues are discussed briefly below.

Reproduction of functional smooth muscle tissue and partial bladder replacement.

The bladder acellular matrix graft (BAMG) appears to serve, without rejection, as a framework of collagen and elastin for the ingrowth of all bladder wall components.

Transitional cell carcinoma of the bladder following augmentation cystoplasty for the neuropathic bladder.

This study supports the hypothesis that bladder augmentation appears to be an independent risk factor for TCC, with a lag time of less than 20 years.

Tissue Engineering in the Genitourinary System

In general, genitourinary tissue has traditionally been replaced with autologous tissues harvested from other sites of the body (Atala and Retik, 1994). However, these approaches rarely replace the

A rabbit model to tissue engineer the bladder.

De novo reconstitution of a functional mammalian urinary bladder by tissue engineering

This study demonstrates, for the first time, that successful reconstitution of an autonomous hollow organ is possible using tissue–engineering methods.